Medical Weight Loss

Physician-Supervised GLP-1 Programs

for Clinically Proven, Sustainable Weight Management at Four Massachusetts Locations

Medical weight loss at GFaceMD is clinically supervised, evidence-based weight management, fundamentally different from commercial diet programs or unsupervised over-the-counter approaches. Physician-supervised weight loss means your program begins with a comprehensive medical assessment, incorporates FDA-approved medications when appropriate, and is monitored and adjusted by licensed medical professionals throughout. At GFaceMD, medical weight management addresses the physiological mechanisms behind weight retention, not just caloric balance, including metabolic rate, hormonal function, and the appetite-regulation pathways targeted by GLP-1 receptor agonist medications.

The evidence base for GLP-1 weight loss treatment has transformed the clinical landscape of weight management. GFaceMD’s program integrates these tools within a structured medical framework, not as a simple prescription service, but as part of a monitored program with regular follow-up, lifestyle guidance, and, where applicable, integration with aesthetic goals.

Our Medical Weight Loss Treatment

GLP-1 Receptor Agonist Program (Available at all four locations)

GLP-1 (glucagon-like peptide-1) receptor agonists are medications designed to mimic a naturally occurring hormone involved in appetite regulation, blood sugar balance, digestion, and satiety. By activating these receptors, GLP-1 therapy may help patients feel fuller longer, reduce food cravings, slow gastric emptying, and support steadier energy levels throughout the day.

 

GLP-1 therapy has become one of the most clinically established long-term tools for medically supervised weight management. Many patients achieve meaningful, sustainable weight reduction when treatment is combined with consistent lifestyle support and ongoing monitoring. Individual results vary depending on medical history, metabolism, adherence, and overall health factors. During your consultation, GFaceMD providers discuss realistic expectations, timelines, and individualized treatment goals based on your specific health profile.

Why Choose GFaceMD?

Physician Supervision:

All programs designed and monitored by licensed medical professionals, including candidacy assessment, prescribing, and ongoing monitoring.

FDA-Approved Medications:

GFaceMD uses only FDA-approved GLP-1 medications, not compounded or unverified alternatives.

Integrated Aesthetic Program:

Significant weight loss can change facial appearance; GFaceMD’s aesthetic expertise enables coordinated treatment planning for patients pursuing both goals.

Regular Monitoring:

The program includes structured follow-up visits to assess progress, adjust dosing, and support long-term success.

Four Massachusetts Locations:

Boston, Wellesley, Andover, and Mashpee.

Common Conditions Addressed

With weight-related health concerns that may benefit from physician-supervised weight loss

Primary candidacy range for GLP-1 medication programs

Elevated blood glucose, insulin resistance, and associated risk factors

Supporting sustainable weight maintenance alongside body contouring or facial aesthetic goals

What Are the Benefits of Medical Weight Loss?

Clinically proven GLP-1 weight loss results

Addresses appetite regulation, metabolic rate, and hormonal factors beyond diet and exercise alone

Physician-supervised program with structured monitoring, not self-managed supplementation

FDA-approved medications with established safety profiles in supervised clinical settings

Integrated with aesthetic treatment planning for comprehensive results

Who Is a Good Candidate for Medical Weight Loss?

You may be a good candidate for GFaceMD’s medical weight loss program if you:

Have a BMI of 27 or above, especially with weight-related health concerns

Have not achieved sustainable results through diet and exercise alone

Are motivated to commit to a structured, medically supervised program Are not pregnant or breastfeeding, and have no medical contraindications to GLP-1 medications

Want physician oversight, regular monitoring, and a personalized protocol, not a commercial program

Available at our Boston, Wellesley, Andover, and Mashpee locations

What to Expect at Your Appointment

1

Medical Assessment:

Full medical history, current medications, BMI, metabolic markers, and weight history were reviewed.

2

Program Design:

Based on your assessment, your provider designs a medical weight management protocol including medication selection, starting dose, and titration plan.

3

Prescription & Education:

GLP-1 medication prescribed if appropriate. Side effect management, injection technique, and lifestyle support were discussed.

4

Follow-Up Schedule:

Regular monitoring visits are scheduled; dosing is adjusted based on response, tolerability, and progress.

How to Prepare

Program Availability by Location

GLP-1 Receptor Agonist Program in Boston, MA

Boston Location img

Book in Boston

GLP-1 Receptor Agonist Program in Wellesley, MA

Wellesley Location img

Book in Wellesley

GLP-1 Receptor Agonist Program in Andover, MA

Andover Location img

Book in Andover

GLP-1 Receptor Agonist Program in Mashpee, MA

Mashpee Location img

Book in Mashpee

Frequently Asked Questions

What is medical weight loss, and how is it different from regular dieting?

Medical weight loss is physician-supervised weight management that incorporates medical assessment, FDA-approved medications when appropriate, and structured monitoring. Unlike commercial programs or self-directed dieting, physician-supervised weight loss addresses the physiological mechanisms, appetite regulation, metabolic rate, and hormonal function that standard dieting cannot change.

GFaceMD prescribes FDA-approved GLP-1 receptor agonist medications. These medications work by mimicking natural gut hormones to reduce appetite, slow gastric emptying, and improve metabolic regulation. GFaceMD uses only FDA-approved formulations, not compounded versions.

Most patients begin seeing weight loss within the first 4–8 weeks. Clinical trials report an average 15% reduction in total body weight over 68 weeks. Results vary based on individual metabolism, starting weight, lifestyle factors, and medication adherence.

Candidates typically have a BMI of 27 or higher, especially when associated with health concerns. Medical history, current medications, and contraindications are assessed at the initial consultation. Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome are not candidates for GLP-1 therapy.

FDA-approved GLP-1 medications have extensive safety data from clinical trials. Common side effects during dose titration include nausea, constipation, and gastrointestinal discomfort, which GFaceMD’s slow-titration protocol is designed to minimize. Medical oversight throughout the program ensures early identification of any concerns.

Ready to Schedule? Book Now

Sustainable weight loss grounded in clinical evidence starts with a physician-supervised program, not a commercial plan. A consultation at GFaceMD assesses your candidacy for medical weight loss and designs a protocol around your specific metabolic profile and goals. Select your nearest location to begin.

Please follow and like us:
Call Now Button